|
Mylan Ready to Launch Generics of Two Sanofi Hypertension Drugs
Mylan is set to begin shipping its generic versions of Sanofi’s hypertension treatments Avapro and Avalide following the FDA’s Friday approval of the company’s ANDAs.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives